Inventor · disambiguated record
Xingming Deng
Also filed as: DENG XINGMING
11 granted patents·6 pending applications·33 citations·filing 2012–2023
86Inventor score
Files withUNIV EMORY9SENGLED OPTOELECTRONICS CO LTD3SENGLED CO LTD2DENG XINGMING1SENGLED OTOELECTRONICS CO LTD1
Top patents by PatentIndex Score
17 records- 0189US9596716B2Wireless network system and smart device management method using LED lighting devicesSENGLED OTOELECTRONICS CO LTD·Filed 2015·Granted Mar 14, 2017·16 cites·15 claims
- 0287US9953520B2LED lighting device, and smart home control system and methodSENGLED OPTOELECTRONICS CO LTD·Filed 2015·Granted Apr 24, 2018·6 cites·18 claims
- 0384US11648221B2KRAS agonists, pharmaceutical compositions, and uses in managing cancerUNIV EMORY·Filed 2020·Granted May 16, 2023·1 cites·8 claims
- 0477US12144791B2KRAS agonists, pharmaceutical compositions, and uses in managing cancerUNIV EMORY·Filed 2023·Granted Nov 19, 2024·0 cites·15 claims
- 0575US9402850B2BAX agonist, compositions, and methods related theretoUNIV EMORY·Filed 2015·Granted Aug 2, 2016·2 cites·5 claims
- 0672US9960475B2LED lighting device and system, and antenna arrangement methodSENGLED OPTOELECTRONICS CO LTD·Filed 2015·Granted May 1, 2018·2 cites·20 claims
- 0771US9955369B2Network self-healing method and system using lighting devicesZHEJIANG SHENGHUI LIGHTING CO·Filed 2015·Granted Apr 24, 2018·2 cites·20 claims
- 0870US9040567B2BAX agonist, compositions, and methods related theretoDENG XINGMING·Filed 2012·Granted May 26, 2015·3 cites·8 claims
- 0963US2023060792A1Targeting Mcl-1 to Enhance DNA Replication Stress Sensitivity for Cancer TherapyUNIV EMORY·Filed 2022·Application pending·0 cites
- 1062US9898910B2System and method for remote monitoring based on LED lighting deviceSENGLED OPTOELECTRONICS CO LTD·Filed 2015·Granted Feb 20, 2018·1 cites·16 claims
- 1161US11524000B2Targeting Mcl-1 to enhance DNA replication stress sensitivity for cancer therapyUNIV EMORY·Filed 2018·Granted Dec 13, 2022·0 cites·7 claims
- 1258US2024342157A1Bak activators, pharmaceutical compositions, and uses in treating cancerUNIV EMORY·Filed 2022·Application pending·0 cites
- 1354US2015065526A1Overcoming acquired resistance to chemotherapy treatments through suppression of stat3UNIV EMORY·Filed 2014·Application pending·0 cites
- 1452US2021137953A1Inhibitors of Mcl-1 and Akt Binding, Pharmaceutical Compositions, and Uses in Treating CancerUNIV EMORY·Filed 2020·Application pending·0 cites
- 1548US9980936B2BH4 antagonists and methods related theretoUNIV EMORY·Filed 2015·Granted May 29, 2018·0 cites·3 claims
- 1640US2018308348A1Wireless voice transparent transmission apparatus and control terminalSENGLED CO LTD·Filed 2018·Application pending·0 cites
- 1735US2018174602A1Speech detection method and apparatusSENGLED CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xingming Deng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →